Dynamic cerebral perfusion parameters and magnetic nanoparticle accumulation assessed by AC biosusceptometry

References

[1] Nikolov N, Makeyev S, Yaroshenko O, Novikova T, Globa M. Quantitative evaluation of the absolute value of the cerebral blood flow according to the scintigraphic studies with 99mTc-HMPAO. Naukovi Visti NTUU KPI 2017;1:618.10.20535/1810-0546.2017.1.91646Suche in Google Scholar

[2] Kuikka J, Ahonen A, Koivula A, Kallanranta T, Laitinen J. An intravenous isotope method for measuring regional cerebral blood flow (rCBF) and volume (rCBV). Phys Med Biol 1977;22:958–70.10.1088/0031-9155/22/5/015Suche in Google Scholar PubMed

[3] Tolonen U, Ahonen A, Sulg I, Kuikka J, Kallanranta T, Koskinen M, et al. Serial measurements of quantitative EEG and cerebral blood flow and circulation time after brain infarction. Acta Neurol Scand 1981;63:145–55.10.1111/j.1600-0404.1981.tb00767.xSuche in Google Scholar PubMed

[4] Leijenaar JF, van Maurik IS, Kuijer JP, van der Flier WM, Scheltens P, Barkhof F, et al. Lower cerebral blood flow in subjects with Alzheimer’s dementia, mild cognitive impairment, and subjective cognitive decline using two-dimensional phase-contrast magnetic resonance imaging. Alzheimers Dement (Amst) 2017;9:76–83.10.1016/j.dadm.2017.10.001Suche in Google Scholar PubMed PubMed Central

[5] Shi Y, Thrippleton MJ, Makin SD, Marshall I, Geerlings MI, de Craen AJ, et al. Cerebral blood flow in small vessel disease: a systematic review and meta-analysis. J Cereb Blood Flow Metab 2016;36:1653–67.10.1177/0271678X16662891Suche in Google Scholar PubMed PubMed Central

[6] Bonnemain B. Superparamagnetic agents in magnetic resonance imaging: physicochemical characteristics and clinical applications. A review. J Drug Target 1998;6:167–74.10.3109/10611869808997890Suche in Google Scholar PubMed

[7] Schwenk MH. Ferumoxytol: a new intravenous iron preparation for the treatment of iron deficiency anemia in patients with chronic kidney disease. Pharmacotherapy 2010;30:70–9.10.1592/phco.30.1.70Suche in Google Scholar PubMed

[8] Cole AJ, Yang VC, David AE. Cancer theranostics: the rise of targeted magnetic nanoparticles. Trends Biotechnol 2011;29: 323–32.10.1016/j.tibtech.2011.03.001Suche in Google Scholar PubMed PubMed Central

[9] Food and Drug Administration. FDA Glossary of Terms [updated 11/14/2017]. Available from: https://www.fda.gov/drugs/informationondrugs/ucm079436.htm. Accessed 15.06.2018.Suche in Google Scholar

[10] Sun C, Lee JS, Zhang M. Magnetic nanoparticles in MR imaging and drug delivery. Adv Drug Deliv Rev 2008;60:1252–65.10.1016/j.addr.2008.03.018Suche in Google Scholar PubMed PubMed Central

[11] Albanese A, Tang PS, Chan WC. The effect of nanoparticle size, shape, and surface chemistry on biological systems. Annu Rev Biomed Eng 2012;14:1–16.10.1146/annurev-bioeng-071811-150124Suche in Google Scholar PubMed

[12] Lacava LM, Lacava ZG, Da Silva MF, Silva O, Chaves SB, Azevedo RB, et al. Magnetic resonance of a dextran-coated magnetic fluid intravenously administered in mice. Biophys J 2001;80:2483–6.10.1016/S0006-3495(01)76217-0Suche in Google Scholar

[13] Huang HS, Hainfeld JF. Intravenous magnetic nanoparticle cancer hyperthermia. Int J Nanomedicine 2013;8:2521–32.10.2147/IJN.S43770Suche in Google Scholar PubMed PubMed Central

[14] Jain TK, Richey J, Strand M, Leslie-Pelecky DL, Flask CA, Labhasetwar V. Magnetic nanoparticles with dual functional properties: drug delivery and magnetic resonance imaging. Biomaterials 2008;29:4012–21.10.1016/j.biomaterials.2008.07.004Suche in Google Scholar PubMed PubMed Central

[15] Weizenecker J, Gleich B, Rahmer J, Dahnke H, Borgert J. Three-dimensional real-time in vivo magnetic particle imaging. Phys Med Biol 2009;54:L1–10.10.1088/0031-9155/54/5/L01Suche in Google Scholar PubMed

[16] Ludewig P, Gdaniec N, Sedlacik J, Forkert ND, Szwargulski P, Graeser M, et al. Magnetic particle imaging for real-time perfusion imaging in acute stroke. ACS Nano 2017;11: 10480–8.10.1021/acsnano.7b05784Suche in Google Scholar PubMed

[17] Gräser M, Thieben F, Szwargulski P, Werner F, Gdaniec N, Boberg M, et al. Human-sized magnetic particle imaging for brain applications. Nat Commun 2019;10:1–9.10.1038/s41467-019-09704-xSuche in Google Scholar PubMed PubMed Central

[18] Cora LA, Americo MF, Romeiro FG, Oliveira RB, Miranda JR. Pharmaceutical applications of AC biosusceptometry. Euro J Pharm Biopharm 2010;74:67–77.10.1016/j.ejpb.2009.05.011Suche in Google Scholar PubMed

[19] Quini CC, Americo MF, Cora LA, Calabresi MF, Alvarez M, Oliveira RB, et al. Employment of a noninvasive magnetic method for evaluation of gastrointestinal transit in rats. J Bio Eng 2012;6:6.10.1186/1754-1611-6-6Suche in Google Scholar PubMed PubMed Central

[20] Quini CC, Prospero AG, Calabresi MFF, Moretto GM, Zufelato N, Krishnan S, et al. Real-time liver uptake and biodistribution of magnetic nanoparticles determined by AC biosusceptometry. Nanomedicine 2017;13:1519–29.10.1016/j.nano.2017.02.005Suche in Google Scholar PubMed

[21] Prospero AG, Quini CC, Bakuzis AF, Fidelis-de-Oliveira P, Moretto GM, Mello FP, et al. Real-time in vivo monitoring of magnetic nanoparticles in the bloodstream by AC biosusceptometry. J Nanobiotechnology 2017;15:22.10.1186/s12951-017-0257-6Suche in Google Scholar PubMed PubMed Central

[22] Quini CC, Matos JF, Prospero AG, Calabresi MFF, Zufelato N, Bakuzis AF, et al. Renal perfusion evaluation by alternating current biosusceptometry of magnetic nanoparticles. J Magn Magn Mater 2015;380:2–6.10.1016/j.jmmm.2014.09.073Suche in Google Scholar

[23] Schroeder U, Sommerfeld P, Ulrich S, Sabel BA. Nanoparticle technology for delivery of drugs across the blood-brain barrier. J Pharm Sci 1998;87:1305–7.10.1021/js980084ySuche in Google Scholar PubMed

[24] Tabatabaei SN, Girouard H, Carret AS, Martel S. Remote control of the permeability of the blood-brain barrier by magnetic heating of nanoparticles: a proof of concept for brain drug delivery. J Control Release 2015;206:49–57.10.1016/j.jconrel.2015.02.027Suche in Google Scholar PubMed

[25] Vilella A, Ruozi B, Belletti D, Pederzoli F, Galliani M, Semeghini V, et al. Endocytosis of nanomedicines: the case of glycopeptide engineered PLGA nanoparticles. Pharmaceutics 2015;7:74–89.10.3390/pharmaceutics7020074Suche in Google Scholar PubMed PubMed Central

[26] von Roemeling C, Jiang W, Chan CK, Weissman IL, Kim BY. Breaking down the barriers to precision cancer nanomedicine. Trends Biotechnol 2017;35:159–71.10.1016/j.tibtech.2016.07.006Suche in Google Scholar PubMed

[27] Lippens RJ. Liposomal daunorubicin (DaunoXome) in children with recurrent or progressive brain tumors. Pediatr Hematol Oncol 1999;16:131–9.10.1080/088800199277452Suche in Google Scholar PubMed

[28] Koukourakis MI, Koukouraki S, Fezoulidis I, Kelekis N, Kyrias G, Archimandritis S, et al. High intratumoural accumulation of stealth liposomal doxorubicin (Caelyx) in glioblastomas and in metastatic brain tumours. Br J Cancer 2000;83:1281–6.10.1054/bjoc.2000.1459Suche in Google Scholar PubMed PubMed Central

[29] Chua SL, Rosenthal MA, Wong SS, Ashley DM, Woods AM, Dowling A, et al. Phase 2 study of temozolomide and Caelyx in patients with recurrent glioblastoma multiforme. Neuro Oncol 2004;6:38–43.10.1215/S1152851703000188Suche in Google Scholar PubMed PubMed Central

[30] Abbott NJ. Blood-brain barrier structure and function and the challenges for CNS drug delivery. J Inherit Metab Dis 2013;36:437–49.10.1007/s10545-013-9608-0Suche in Google Scholar PubMed

[31] Rapoport SI. Osmotic opening of the blood-brain barrier: principles, mechanism, and therapeutic applications. Cell Mol Neurobiol 2000;20:217–30.10.1023/A:1007049806660Suche in Google Scholar

[32] Muizelaar JP, Wei EP, Kontos HA, Becker DP. Mannitol causes compensatory cerebral vasoconstriction and vasodilation in response to blood viscosity changes. J Neurosurg 1983;59:822–8.10.3171/jns.1983.59.5.0822Suche in Google Scholar

[33] Kim JS, Yoon TJ, Yu KN, Kim BG, Park SJ, Kim HW, et al. Toxicity and tissue distribution of magnetic nanoparticles in mice. Toxicol Sci 2006;89:338–47.10.1093/toxsci/kfj027Suche in Google Scholar

[34] Branquinho LC, Carriao MS, Costa AS, Zufelato N, Sousa MH, Miotto R, et al. Effect of magnetic dipolar interactions on nanoparticle heating efficiency: implications for cancer hyperthermia. Sci Rep UK 2014;4:3637.10.1038/srep02887Suche in Google Scholar

[35] Rodrigues HF, Capistrano G, Mello FM, Zufelato N, Silveira-Lacerda E, Bakuzis AF. Precise determination of the heat delivery during in vivo magnetic nanoparticle hyperthermia with infrared thermography. Phys Med Biol 2017;62:4062–82.10.1088/1361-6560/aa6793Suche in Google Scholar

[36] Silva AC, Bock NA. Manganese-enhanced MRI: an exceptional tool in translational neuroimaging. Schizophr Bull 2008;34:595–604.10.1093/schbul/sbn056Suche in Google Scholar

[37] Bock NA, Paiva FF, Silva AC. Fractionated manganese-enhanced MRI. NMR Biomed 2008;21:473–8.10.1002/nbm.1211Suche in Google Scholar

[38] Zhang S, Zhou Z, Fu J. Effect of manganese chloride exposure on liver and brain mitochondria function in rats. Environ Res 2003;93:149–57.10.1016/S0013-9351(03)00109-9Suche in Google Scholar

[39] Miranda JRA, Oliveira RB, Sousa PL, Braga FJH, Baffa O. A novel biomagnetic method to study gastric antral contractions. Phys Med Biol 1997;42:1791–9.10.1088/0031-9155/42/9/010Suche in Google Scholar PubMed

[40] Baffa O, Oliveira RB, Miranda JR, Troncon LE. Analysis and development of AC biosusceptometer for orocaecal transit time measurements. Med Biol Eng Comput 1995;33:353–7.10.1007/BF02510514Suche in Google Scholar PubMed

[41] Americo MF, Oliveira RB, Romeiro FG, Baffa O, Cora LA, Miranda JR. Scintigraphic validation of AC biosusceptometry to study the gastric motor activity and the intragastric distribution of food in humans. Neurogastroenterol Motil 2007;19:804–11.10.1111/j.1365-2982.2007.00960.xSuche in Google Scholar PubMed

[42] Oliveira RB, Baffa O, Troncon LEA, Miranda JRA, Cambrea CR. Evaluation of a biomagnetic technique for measurement of orocaecal transit time. Eur J Gastroenterol Hepatol 1996;8:491–5.Suche in Google Scholar

[43] Suthummanon S, Omachonu VK, Akcin M. Applying activity-based costing to the nuclear medicine unit. Health Serv Manage Res 2005;18:141–50.10.1258/0951484054572538Suche in Google Scholar

[44] Choi HS, Liu W, Misra P, Tanaka E, Zimmer JP, Itty Ipe B, et al. Renal clearance of quantum dots. Nat Biotechnol 2007;25:1165–70.10.1038/nbt1340Suche in Google Scholar

[45] Chen LT, Weiss L. The role of the sinus wall in the passage of erythrocytes through the spleen. Blood 1973;41:529–37.10.1182/blood.V41.4.529.529Suche in Google Scholar

[46] Bereczki D, Liu M, do Prado GF, Fekete I. Mannitol for acute stroke. Cochrane Database Syst Rev 2007;3:1–16.10.1002/14651858.CD001153Suche in Google Scholar

[47] Bereczki D, Liu M, Prado GF, Fekete I. Cochrane report: a systematic review of mannitol therapy for acute ischemic stroke and cerebral parenchymal hemorrhage. Stroke 2000;31:2719–22.10.1161/01.STR.31.11.2719Suche in Google Scholar

[48] Alam MI, Beg S, Samad A, Baboota S, Kohli K, Ali J, et al. Strategy for effective brain drug delivery. Eur J Pharm Sci 2010;40:385–403.10.1016/j.ejps.2010.05.003Suche in Google Scholar

[49] Sahoo SK, Labhasetwar V. Nanotech approaches to drug delivery and imaging. Drug Discov Today 2003;8:1112–20.10.1016/S1359-6446(03)02903-9Suche in Google Scholar

[50] Singh R, Lillard Jr JW. Nanoparticle-based targeted drug delivery. Exp Mol Pathol 2009;86:215–23.10.1016/j.yexmp.2008.12.004Suche in Google Scholar PubMed PubMed Central

[51] Wadghiri YZ, Sigurdsson EM, Sadowski M, Elliott JI, Li Y, Scholtzova H, et al. Detection of Alzheimer’s amyloid in transgenic mice using magnetic resonance microimaging. Magn Reson Med 2003;50:293–302.10.1002/mrm.10529Suche in Google Scholar PubMed

[52] Son S, Jang J, Youn H, Lee S, Lee D, Lee Y-S, et al. A brain-targeted rabies virus glycoprotein-disulfide linked PEI nanocarrier for delivery of neurogenic microRNA. Biomaterials 2011;32:4968–75.10.1016/j.biomaterials.2011.03.047Suche in Google Scholar PubMed

[53] Oliveira RR, Carrião MS, Pacheco MT, Branquinho LC, de Souza ALR, Bakuzis AF, et al. Triggered release of paclitaxel from magnetic solid lipid nanoparticles by magnetic hyperthermia. Mat Sci Eng C 2018;92:547–53.10.1016/j.msec.2018.07.011Suche in Google Scholar PubMed

[54] Fantini S, Sassaroli A, Tgavalekos KT, Kornbluth J. Cerebral blood flow and autoregulation: current measurement techniques and prospects for noninvasive optical methods. Neurophotonics 2016;3:031411.10.1117/1.NPh.3.3.031411Suche in Google Scholar PubMed PubMed Central

[55] Ficko BW, Giacometti P, Diamond SG. Nonlinear susceptibility magnitude imaging of magnetic nanoparticles. J Magn Magn Mater 2015;378:267–77.10.1016/j.jmmm.2014.11.049Suche in Google Scholar PubMed PubMed Central